Conversely, silencing of GSK3A and GSK3B drastically reduced the expression of the gene sets that characterize tissue-resident lung alveolar macrophages in COVID-19, with the concomitant silencing of GSK3A and GSK3B again showing a stronger effect (Figure 4I). The gene discussed is GSK3B; the disease is COVID-19.